Michael Yee

Michael Yee Analyst Performance

Global Head of Biotechnology Equity Research & Managing Director - Senior Biotechnology Analyst at UBS Group

Michael Yee is a stock analyst at UBS Group focused in the healthcare sector, covering 51 publicly traded companies. Over the past year, Michael Yee has issued 115 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Michael Yee's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Yee's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
224 Last 12 Years
Buy Recommendations
83.49% 182 Buy Ratings
Companies Covered
51 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.9%2 ratings
Buy82.6%180 ratings
Hold16.1%35 ratings
Sell0.5%1 ratings

Out of 218 total stock ratings issued by Michael Yee at UBS Group, the majority (82.6%) have been Buy recommendations, followed by 16.1% Hold, 0.9% Strong Buy, and 0.5% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
86.3% of companies on NASDAQ
44 companies
NYSE
13.7% of companies on NYSE
7 companies

Michael Yee, an analyst at UBS Group, currently covers 51 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
49 companies
96.1%
Miscellaneous
2 companies
3.9%

Michael Yee of UBS Group specializes in stock coverage within the Healthcare sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
40 companies
78.4%
PHARMACEUTICALS
8 companies
15.7%
Miscellaneous
2 companies
3.9%
HEALTHCARE TECHNOLOGY
1 company
2.0%

Michael Yee's Ratings History at UBS Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
11/13/2026Boost Price Target$107.98$150.00Buy
Pfizer Inc. stock logo
PFE
Pfizer
11/4/2026Boost Price Target$30.79$30.00Neutral
Amgen Inc. stock logo
AMGN
Amgen
11/4/2026Boost Price Target$478.48$530.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
11/3/2026Boost Price Target$535.80$640.00Buy
AbbVie Inc. stock logo
ABBV
AbbVie
11/2/2026Boost Price Target$294.80$295.00Neutral
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
10/30/2026Boost Price Target$170.86$195.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
10/30/2026Boost Price Target$1,372.01$1,625.00Buy
Biogen Inc. stock logo
BIIB
Biogen
10/29/2026Boost Price Target$251.60$300.00Buy
ADRX
ADARx Pharmaceuticals
10/20/2026Initiated Coverage$17.63$35.00Buy
ADRX
ADARx Pharmaceuticals
10/20/2026Initiated Coverage$17.68$35.00Buy
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
10/14/2026Set Price Target$248.90$270.00
Biogen Inc. stock logo
BIIB
Biogen
10/9/2026Boost Price Target$221.86$270.00Buy
Amgen Inc. stock logo
AMGN
Amgen
10/9/2026Boost Price Target$411.13$470.00Buy
AbbVie Inc. stock logo
ABBV
AbbVie
10/6/2026Boost Price Target$263.24$275.00Neutral
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
9/28/2026Reiterated Rating$55.72Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
9/28/2026Boost Price Target$528.06$615.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
9/28/2026Boost Price Target$88.13$120.00Buy
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
9/22/2026Reiterated Rating$269.08Buy
Moderna, Inc. stock logo
MRNA
Moderna
9/22/2026Reiterated Rating$183.42Neutral
Amgen Inc. stock logo
AMGN
Amgen
9/17/2026Reiterated Rating$378.36$430.00Buy
TRAX
First Tracks Biotherapeutics
9/16/2026Initiated Coverage$38.47Buy
Cyclerion Therapeutics, Inc. stock logo
KRSA
Cyclerion Therapeutics
9/10/2026Upgrade$31.91Strong-Buy
Moderna, Inc. stock logo
MRNA
Moderna
9/3/2026Set Price Target$150.81$81.00
Moderna, Inc. stock logo
MRNA
Moderna
9/3/2026Downgrade$150.81Sell
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
9/2/2026Initiated Coverage$279.78$320.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
8/28/2026Boost Price Target$221.15$265.00Buy
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
8/20/2026Boost Price Target$151.73$175.00Buy
Schrodinger, Inc. stock logo
SDGR
Schrodinger
8/14/2026Initiated Coverage$18.46$19.00Neutral
Schrodinger, Inc. stock logo
SDGR
Schrodinger
8/14/2026Initiated Coverage$18.46$19.00Neutral
TRAX
First Tracks Biotherapeutics
8/10/2026Boost Price Target$46.70$65.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
8/7/2026Set Price Target$1,177.47$1,376.00
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
8/7/2026Boost Price Target$24.58$34.00Buy
Amgen Inc. stock logo
AMGN
Amgen
8/5/2026Boost Price Target$407.83$440.00Buy
Biogen Inc. stock logo
BIIB
Biogen
7/30/2026Boost Price Target$204.32$240.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
7/13/2026Boost Price Target$481.82$585.00Buy
Amgen Inc. stock logo
AMGN
Amgen
7/13/2026Boost Price Target$358.76$420.00Buy
AbbVie Inc. stock logo
ABBV
AbbVie
7/13/2026Boost Price Target$246.93$260.00Neutral
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
7/13/2026Boost Price Target$1,188.32$1,425.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
7/1/2026Boost Price Target$95.17$130.00Buy
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
6/23/2026Downgrade$132.55$135.11Neutral
My public warning after 55 years of watching the markets (Ad)

Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel

See Martin Weiss's full warning before this risk spreads further
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
6/15/2026Initiated Coverage$15.34$45.00Buy
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
6/15/2026Initiated Coverage$16.10$45.00Buy
Pfizer Inc. stock logo
PFE
Pfizer
5/27/2026Reiterated Rating$26.34$27.00Neutral
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
5/13/2026Boost Price Target$65.58$76.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/28/2026Boost Price Target$82.12$100.00Buy
Biogen Inc. stock logo
BIIB
Biogen
4/22/2026Upgrade$185.95$225.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
4/21/2026Lower Price Target$53.19$60.00Buy
Amgen Inc. stock logo
AMGN
Amgen
4/13/2026Boost Price Target$349.82$400.00Buy
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
4/13/2026Boost Price Target$120.19$145.00Buy
Pfizer Inc. stock logo
PFE
Pfizer
4/13/2026Boost Price Target$27.32$27.00Neutral
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/6/2026Boost Price Target$55.82$75.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
3/27/2026Boost Price Target$41.92$80.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
3/18/2026Reiterated Rating$915.76Buy
Schrodinger, Inc. stock logo
SDGR
Schrodinger
3/17/2026Lower Price Target$12.48$13.00Neutral
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
3/17/2026Boost Price Target$66.88$90.00Buy
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
3/6/2026Reiterated Rating$60.69$70.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
3/3/2026Lower Price Target$4.48$7.00Neutral
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
2/24/2026Reiterated Rating$37.10Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
2/24/2026Downgrade$113.75$115.00Neutral
Damora Therapeutics, Inc. Common Stock stock logo
DMRA
Damora Therapeutics, Inc. Common Stock
2/17/2026Initiated Coverage$29.12$45.00Buy
AbbVie Inc. stock logo
ABBV
AbbVie
2/5/2026Lower Price Target$217.41$230.00Neutral
AbbVie Inc. stock logo
ABBV
AbbVie
2/5/2026Upgrade$220.74Hold
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2/2/2026Reiterated Rating$1,050.45Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/26/2026Boost Price Target$473.83$545.00Buy
Amgen Inc. stock logo
AMGN
Amgen
1/26/2026Boost Price Target$349.03$390.00Buy
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/26/2026Boost Price Target$137.73$155.00Buy
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/15/2026Reiterated Rating$122.83Buy
AbbVie Inc. stock logo
ABBV
AbbVie
1/13/2026Reiterated Rating$220.24Neutral
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/8/2026Reiterated Rating$13.73$14.00Neutral
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/8/2026Downgrade$13.81$14.00Hold
Arcellx, Inc. stock logo
ACLX
Arcellx
1/7/2026Initiated Coverage$62.98Buy
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
1/7/2026Initiated Coverage$17.72Buy
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
1/7/2026Initiated Coverage$31.05$50.00Buy
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/7/2026Initiated Coverage$10.05$20.00Buy
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
1/7/2026Initiated Coverage$1.41$8.00Buy
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
1/7/2026Initiated Coverage$18.20$35.00Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
1/7/2026Initiated Coverage$41.31$60.00Buy
Schrodinger, Inc. stock logo
SDGR
Schrodinger
1/7/2026Initiated Coverage$18.79$18.00Neutral
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
1/7/2026Initiated Coverage$3.62$7.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
1/7/2026Initiated Coverage$26.62$50.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
1/7/2026Initiated Coverage$25.04$45.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
1/7/2026Initiated Coverage$8.47$10.00Neutral
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
1/7/2026Initiated Coverage$25.05$50.00Buy
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
1/7/2026Initiated Coverage$28.70$60.00Buy
Inventiva S.A. Sponsored ADR stock logo
IVA
Inventiva
1/7/2026Initiated Coverage$4.54$12.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
1/7/2026Set Price Target$32.85$55.00Buy
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
1/7/2026Initiated Coverage$17.21$25.00Buy
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
1/7/2026Initiated Coverage$28.34$28.00Neutral
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
1/7/2026Initiated Coverage$43.91$70.00Buy
Aligos Therapeutics, Inc. stock logo
ALGS
Aligos Therapeutics
1/7/2026Initiated Coverage$8.76$20.00Buy
Why I'm selling my Snapback Indicator for just $7 (Ad)

For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel

Get lifetime access to the Snapback Indicator for a one-time $7 payment today.
Arcellx, Inc. stock logo
ACLX
Arcellx
1/7/2026Initiated Coverage$62.06$100.00Buy
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
1/7/2026Upgrade$54.45$65.00Buy
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/7/2026Initiated Coverage$121.36$145.00Buy
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
1/7/2026Initiated Coverage$37.28$50.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
1/7/2026Upgrade$33.76$55.00Buy
Aligos Therapeutics, Inc. stock logo
ALGS
Aligos Therapeutics
1/7/2026Initiated Coverage$10.33$20.00Buy
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
1/7/2026Initiated Coverage$1.49$8.00Buy
Amgen Inc. stock logo
AMGN
Amgen
1/7/2026Upgrade$330.11Strong-Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
1/7/2026Reiterated Rating$43.80$70.00Buy
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
1/7/2026Initiated Coverage$28.00$28.00Hold
Inventiva S.A. Sponsored ADR stock logo
IVA
Inventiva
1/7/2026Reiterated Rating$4.92$12.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
1/7/2026Initiated Coverage$26.62$50.00Buy
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
1/7/2026Initiated Coverage$30.72$60.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
1/7/2026Initiated Coverage$8.46$10.00Hold
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
1/7/2026Initiated Coverage$25.57$45.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
1/7/2026Initiated Coverage$26.40$50.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
1/7/2026Initiated Coverage$3.86$7.00Buy
Schrodinger, Inc. stock logo
SDGR
Schrodinger
1/7/2026Initiated Coverage$18.61$18.00Hold
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
1/7/2026Initiated Coverage$41.67$60.00Buy
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
1/7/2026Initiated Coverage$30.33$50.00Buy
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/7/2026Initiated Coverage$13.84$20.00Buy
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
1/7/2026Initiated Coverage$18.50$35.00Buy
Biogen Inc. stock logo
BIIB
Biogen
1/6/2026Initiated Coverage$182.61$185.00Neutral
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/6/2026Initiated Coverage$468.58$535.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1/6/2026Initiated Coverage$1,063.95$1,250.00Buy
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
3/6/2025Upgrade$1.04$3.00Buy